MoneyWorks4Me

Dr. Reddy's Laboratories informs about press release

04 Sep 2021 Evaluate

Dr. Reddy's Laboratories has informed that it enclosed a Press Release on 4th September titled ‘Dr. Reddy's Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)’.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..